Predictors of blood pressure response in the SYMPLICITY HTN-3 trial (Q34994094)

5 August 2017

title

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial (English)

1 reference

5 August 2017

2

Deepak L Bhatt

1 reference

5 August 2017

14

Laura Mauri

1 reference

5 August 2017

1

David E Kandzari

1 reference

5 August 2017

13

Joseph Massaro

1 reference

5 August 2017

11

Martin B Leon

1 reference

5 August 2017

21

Raymond R Townsend

1 reference

5 August 2017

7

John M Flack

1 reference

5 August 2017

Barry Theodore Katzen

8

object named as

Barry T Katzen

1 reference

5 August 2017

15

Suzanne Oparil

1 reference

5 August 2017

Krishna J Rocha-Singh

18

object named as

Krishna Rocha-Singh

1 reference

5 August 2017

22

George L Bakris

1 reference

5 August 2017

19

Paul A Sobotka

1 reference

5 August 2017

4

Chandan M Devireddy

1 reference

5 August 2017

17

Manesh R Patel

1 reference

5 August 2017

Sandeep Brar

3

1 reference

5 August 2017

Murray Esler

5

1 reference

5 August 2017

Martin Fahy

6

1 reference

5 August 2017

Janice Lea

9

1 reference

5 August 2017

David P Lee

10

1 reference

5 August 2017

Adrian Ma

12

1 reference

5 August 2017

William W O'Neill

16

1 reference

5 August 2017

Laura Svetkey

20

1 reference

5 August 2017

publication date

16 November 2014

1 reference

5 August 2017

published in

European Heart Journal

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

219-227

1 reference

Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

A controlled trial of renal denervation for resistant hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Translational medicine: the antihypertensive effect of renal denervation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Hypertension in adults across the age spectrum: current outcomes and control in the community

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Sympathectomy in the treatment of benign and malignant hypertension; a review of 76 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Neural control of renal function

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301597

Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU441

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU441

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU441

Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006

21 January 2018

1 reference

12 December 2020

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

1 reference

12 December 2020

Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial

1 reference

12 December 2020

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

1 reference

12 December 2020

Resistant hypertension? Assessment of adherence by toxicological urine analysis

1 reference

12 December 2020

Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus

1 reference

12 December 2020

Sustained Sympathetic and Blood Pressure Reduction 1 Year After Renal Denervation in Patients With Resistant Hypertension

1 reference

12 December 2020

Anatomic assessment of sympathetic peri-arterial renal nerves in man

1 reference

12 December 2020

Central and Peripheral Norepinephrine Kinetics in Heart Failure, Coronary Artery Disease, and Hypertension

1 reference

12 December 2020

Splanchnicectomy for essential hypertension; results in 1,266 cases

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHU441

1 reference

5 August 2017

1 reference

5 August 2017

1 reference